Home > Research > Publications & Outputs > Growing medicine

Associated organisational unit

View graph of relations

Growing medicine: small-scale cannabis cultivation for medical purposes in six countries

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Published

Standard

Growing medicine: small-scale cannabis cultivation for medical purposes in six countries. / Hakkarainen, Pekka; Frank, Vibeke Asmussen; Barratt, Monica et al.
In: International Journal of Drug Policy, Vol. 26, No. 3, 03.2015, p. 250-256.

Research output: Contribution to Journal/MagazineJournal articlepeer-review

Harvard

Hakkarainen, P, Frank, VA, Barratt, M, Dahl, H, Decorte, T, Karjalainen, K, Lenton, S, Potter, G & Werse, B 2015, 'Growing medicine: small-scale cannabis cultivation for medical purposes in six countries', International Journal of Drug Policy, vol. 26, no. 3, pp. 250-256. https://doi.org/10.1016/j.drugpo.2014.07.005

APA

Hakkarainen, P., Frank, V. A., Barratt, M., Dahl, H., Decorte, T., Karjalainen, K., Lenton, S., Potter, G., & Werse, B. (2015). Growing medicine: small-scale cannabis cultivation for medical purposes in six countries. International Journal of Drug Policy, 26(3), 250-256. https://doi.org/10.1016/j.drugpo.2014.07.005

Vancouver

Hakkarainen P, Frank VA, Barratt M, Dahl H, Decorte T, Karjalainen K et al. Growing medicine: small-scale cannabis cultivation for medical purposes in six countries. International Journal of Drug Policy. 2015 Mar;26(3):250-256. doi: 10.1016/j.drugpo.2014.07.005

Author

Hakkarainen, Pekka ; Frank, Vibeke Asmussen ; Barratt, Monica et al. / Growing medicine : small-scale cannabis cultivation for medical purposes in six countries. In: International Journal of Drug Policy. 2015 ; Vol. 26, No. 3. pp. 250-256.

Bibtex

@article{320d7b564925426e8271e760b6014a8e,
title = "Growing medicine: small-scale cannabis cultivation for medical purposes in six countries",
abstract = "BACKGROUND:The production and consumption of cannabis for the treatment of medical conditions is of increasing importance internationally; however, research on different aspects of the phenomenon is still scarce. In this article, we report findings from a cross-cultural study of small-scale cannabis cultivation for medical purposes. This kind of comparative study has not been done previously.METHODS:The data were gathered with a help of web surveys conducted by the Global Cannabis Cultivation Research Consortium (GCCRC) in Australia, Belgium, Denmark, Finland, Germany and the UK (N=5313). In the analysis we compare reports of medical motives, for what conditions cannabis is used, whether users have diagnoses for these conditions and whether the use of cannabis been recommended as a treatment of those conditions by a medical doctor. Descriptive statistics are used to show the main commonalities and noteworthy disparities across different countries.RESULTS:Findings from countries were quite similar, even though several national differences in details were found. Growing cannabis for medical purposes was widespread. The majority of medical growers reported cultivating cannabis for serious conditions. Most of them did have a formal diagnosis. One fifth had got a recommendation from their doctor, but in most cases cannabis use was self-medication which was not discussed with their doctors.CONCLUSION:There is a wider demand for licit access for medical cannabis than currently available in these countries. Ideologically, medical growers can be seen distancing themselves from both the legal and illicit drug markets. From a harm reduction perspective, it is worrying that, in the context of present health and control policies in these countries, many medical growers are using cannabis to treat serious medical conditions without proper medical advice and doctor's guidance.",
keywords = "Cannabis, Small-scale cannabis cultivation, Medical use of cannabis, Cross-cultural study, Web survey",
author = "Pekka Hakkarainen and Frank, {Vibeke Asmussen} and Monica Barratt and Helle Dahl and Tom Decorte and Karoliina Karjalainen and Simon Lenton and Gary Potter and Bernd Werse",
year = "2015",
month = mar,
doi = "10.1016/j.drugpo.2014.07.005",
language = "English",
volume = "26",
pages = "250--256",
journal = "International Journal of Drug Policy",
issn = "0955-3959",
publisher = "Elsevier",
number = "3",

}

RIS

TY - JOUR

T1 - Growing medicine

T2 - small-scale cannabis cultivation for medical purposes in six countries

AU - Hakkarainen, Pekka

AU - Frank, Vibeke Asmussen

AU - Barratt, Monica

AU - Dahl, Helle

AU - Decorte, Tom

AU - Karjalainen, Karoliina

AU - Lenton, Simon

AU - Potter, Gary

AU - Werse, Bernd

PY - 2015/3

Y1 - 2015/3

N2 - BACKGROUND:The production and consumption of cannabis for the treatment of medical conditions is of increasing importance internationally; however, research on different aspects of the phenomenon is still scarce. In this article, we report findings from a cross-cultural study of small-scale cannabis cultivation for medical purposes. This kind of comparative study has not been done previously.METHODS:The data were gathered with a help of web surveys conducted by the Global Cannabis Cultivation Research Consortium (GCCRC) in Australia, Belgium, Denmark, Finland, Germany and the UK (N=5313). In the analysis we compare reports of medical motives, for what conditions cannabis is used, whether users have diagnoses for these conditions and whether the use of cannabis been recommended as a treatment of those conditions by a medical doctor. Descriptive statistics are used to show the main commonalities and noteworthy disparities across different countries.RESULTS:Findings from countries were quite similar, even though several national differences in details were found. Growing cannabis for medical purposes was widespread. The majority of medical growers reported cultivating cannabis for serious conditions. Most of them did have a formal diagnosis. One fifth had got a recommendation from their doctor, but in most cases cannabis use was self-medication which was not discussed with their doctors.CONCLUSION:There is a wider demand for licit access for medical cannabis than currently available in these countries. Ideologically, medical growers can be seen distancing themselves from both the legal and illicit drug markets. From a harm reduction perspective, it is worrying that, in the context of present health and control policies in these countries, many medical growers are using cannabis to treat serious medical conditions without proper medical advice and doctor's guidance.

AB - BACKGROUND:The production and consumption of cannabis for the treatment of medical conditions is of increasing importance internationally; however, research on different aspects of the phenomenon is still scarce. In this article, we report findings from a cross-cultural study of small-scale cannabis cultivation for medical purposes. This kind of comparative study has not been done previously.METHODS:The data were gathered with a help of web surveys conducted by the Global Cannabis Cultivation Research Consortium (GCCRC) in Australia, Belgium, Denmark, Finland, Germany and the UK (N=5313). In the analysis we compare reports of medical motives, for what conditions cannabis is used, whether users have diagnoses for these conditions and whether the use of cannabis been recommended as a treatment of those conditions by a medical doctor. Descriptive statistics are used to show the main commonalities and noteworthy disparities across different countries.RESULTS:Findings from countries were quite similar, even though several national differences in details were found. Growing cannabis for medical purposes was widespread. The majority of medical growers reported cultivating cannabis for serious conditions. Most of them did have a formal diagnosis. One fifth had got a recommendation from their doctor, but in most cases cannabis use was self-medication which was not discussed with their doctors.CONCLUSION:There is a wider demand for licit access for medical cannabis than currently available in these countries. Ideologically, medical growers can be seen distancing themselves from both the legal and illicit drug markets. From a harm reduction perspective, it is worrying that, in the context of present health and control policies in these countries, many medical growers are using cannabis to treat serious medical conditions without proper medical advice and doctor's guidance.

KW - Cannabis

KW - Small-scale cannabis cultivation

KW - Medical use of cannabis

KW - Cross-cultural study

KW - Web survey

U2 - 10.1016/j.drugpo.2014.07.005

DO - 10.1016/j.drugpo.2014.07.005

M3 - Journal article

VL - 26

SP - 250

EP - 256

JO - International Journal of Drug Policy

JF - International Journal of Drug Policy

SN - 0955-3959

IS - 3

ER -